von Richter, Oliver <br/><br/>
Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide.  [electronic resource] 

 -  Clinical pharmacokinetics  2007 
 - 613-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0312-5963 
<br/><br/><label>Standard No.: </label>10.2165/00003088-200746070-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases--antagonists & inhibitors<br/>Administration, Oral<br/>Adult<br/>Aminopyridines--administration & dosage<br/>Anti-Anxiety Agents--administration & dosage<br/>Area Under Curve<br/>Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors<br/>Benzamides--administration & dosage<br/>Cross-Over Studies<br/>Cyclic Nucleotide Phosphodiesterases, Type 4<br/>Cyclopropanes--administration & dosage<br/>Cytochrome P-450 CYP1A2<br/>Cytochrome P-450 CYP1A2 Inhibitors<br/>Cytochrome P-450 CYP2C19<br/>Female<br/>Fluvoxamine--administration & dosage<br/>Half-Life<br/>Humans<br/>Male<br/>Middle Aged<br/>Mixed Function Oxygenases--antagonists & inhibitors<br/>Phosphodiesterase Inhibitors--administration & dosage<br/>Tablets<br/>Time Factors